Strides Pharma Soars 10% On Development Of Antivirals For Covid-19
Strides Pharma shares zoomed more than 10 per cent on the BSE on Thursday after the company said that it has developedFavipiravir antiviral tablets for the treatment of COVID-19.
Strides Pharma shares zoomed more than 10 per cent on the BSE on Thursday after the company said that it has developedFavipiravir antiviral tablets for the treatment of COVID-19.